Characterization of the cheetah serum amyloid A1 gene: Critical role and functional polymorphism of a Cis-acting element

Journal of Heredity

Volumn 99, Issue 4, 2008, Pages 355-363

  Zhang, Beiru ^a,c   Une, Yumi ^b   Ge, Fengxia ^a   Fu, Xiaoying ^a   Qian, Jinze ^a   Zhang, Pengyao ^a,c   Sawashita, Jinko ^a   Higuchi, Keiichi ^a   Mori, Masayuki ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AZABU UNIVERSITY   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CIS ACTING ELEMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CHEETAH; DNA FLANKING REGION; DNA POLYMORPHISM; ENHANCER REGION; GENETIC IDENTIFICATION; GENETIC TRAIT; GENOME; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SERUM AMYLOID A1 GENE; TRANSCRIPTION INITIATION;

ACINONYX; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; REGULATORY SEQUENCES, NUCLEIC ACID; SERUM AMYLOID A PROTEIN;

ACINONYX JUBATUS;

EID: 44449097903     PISSN: 00221503     EISSN: 14657333     Source Type: Journal    
DOI: 10.1093/jhered/esn015     Document Type: Article

References (40)

1. Aldo-Benson MA, Benson MD. 1982. SAA suppression of immune response in vitro: evidence for an effect on T-cell macrophage interaction. J Immunol. 128:2390-2392.
2. Baba S, Takahashi T, Kasama T, Shirasawa H. 1992. Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis. Biochim Biophys Acta. 1180:195-200.
3. Bell AW, Chan SL, Marcantonio D, Ali-Kahn Z. 1996. Both murine SAA1 and SAA2 yield AA amyloid in alveolar hydatid cyst-infected mice. Scand J Immunol. 43:173-180.
4. Benson MD, Kleiber E. 1980. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. J Immunol. 124:495-499.
5. Bergström J, Ueda M, Une Y, Sun X, Misumi S, Shoji S, Ando Y. 2006. Analysis of amyloid fibrils in the cheetah (Acinonyx jubatus). Amyloid. 13:93-98.
6. Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P. 1993. The role of NF-kappaB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem. 268:25624-25631.
7. Edbrooke MR, Burt DW, Cheshire JK, Woo P. 1989. Identification of cis-acting sequence responsible for phorbol ester induction of human serum amyloid A gene expression via nuclear factor kappaB-like transcription factor. Mol Cell Biol. 9:1908-1916.
8. Edbrooke MR, Foldi J, Cheshire JK, Li F, Faulkes DJ, Woo P. 1991. Constitutive and NF-kappa B-like proteins in the regulation of the serum amyloid gene by interleukin 1. Cytokine. 3:380-388.
9. Glenner GG. 1980. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med. 302:1283-1292.
10. Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, Taga T, Yoshizaki K. 2005. Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells. 10:1051-1063.
11. Hoffman JS, Benditt EP. 1982. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions. J Biol Chem. 257:10510-10517.
12. Hoffman JS, Ericsson LH, Eriksen N, Walsh KA, Benditt EP. 1984. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med. 159:641-646.
13. Husebekk A, Skogen B, Husby G, Marhaug G. 1985. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol. 21:283-287.
14. Johnson KH, Sletten K, Munson L, O'Brien TD, Papendick R, Westermark P. 1997. Amino acid sequence analysis of amyloid protein A (AA) from cats (captive cheetahs: Acinonyx jubatus) with a high prevalence of AA amyloidosis. Amyloid: Int J Exp Clin Invest. 4:171-177.
15. Johnson KH, Westermark P, Sletten K, O'Brien TD. 1996. Amyloid proteins and amyloidosis in domestic animals. Amyloid: Int J Exp Clin Invest. 3:270-289.
16. Kisilevsky R, Subrahmanyan L. 1992. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest. 66:778-785.
17. Kumon Y, Suehiro T, Faulkes DJ, Hosakawa T, Ikeda Y, Woo P, Dipe JD, Hashimoto K. 2002. Transcriptional regulation of serum amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/enhancer binding protein (C/EBP) and is distinct from HepG2 cells. Scand J Immunol. 56:504-511.
18. Larson MA, Wei SH, Weber A, Weber AT, McDonald TL. 2003. Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide. Biochem Biophys Res Commun. 301:1030-1037.
19. Li X, Liao WSL. 1992. Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells. Nucleic Acids Res. 20:4765-4772.
20. Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD. 1997. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neuroscience. 225:73-76.
21. Liepnieks JJ, Kluve-Beckerman B, Benson MD. 1995. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta. 1270:81-86.
22. Linke RP, Bock V, Valet G, Roth G. 1991. Inhibition of the oxidative burst response of N formyl peptide stimulated neutrophils by serum amyloid A protein. Biochem Biophys Res Commun. 176:1100-1105.
23. Liu Y, Cui D, Hoshii Y, Kawano H, Une Y, Gondo T, Ishihara T. 2007. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides. Scand J Immunol. 66:495-500.
24. Lowell CA, Potter DA, Stearman RS, Morrow JF. 1986. Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem. 261:8442-8452.
25. McAdam KP, Sipe JD. 1976. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med. 144:1121-1127.
26. Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, Inada S, Kitamura Y, Kamatani N. 2005. Relative transcriptional activities of SAA1 promoters polymorphic at position -13(T/C): potential association between increased transcription and amyloidosis. Amyloid. 12:26-32.
27. Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, Kamatani N. 2001. A novel single-nucleotide polymorphism at the 5′-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum. 44:1266-1272.
28. Morrow JF, Stearman RS, Peltzman CG, Potter DA. 1981. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA. 78:4718-4722.
29. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T. 2004. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 50:1761-1769.
30. O'Brien SJ, Roelke ME, Marker L, Newman A, Winkler CA, Meltzer D, Colly L, Evermann JF, Bush M, Wildt DE. 1985. Genetic basis for species vulnerability in the cheetah. Science. 227:1428-1434.
31. Papendick RE, Munson L, O'Brien TD, Johnson KH. 1997. Systemic AA amyloidosis in captive cheetahs (Acinonyx jubatus). Vet Pathol. 34:549-556.
32. Ray A, Ray BK. 1993. Analysis of the promoter element of the serum amyloid A gene and its interaction with constitutive and inducible nuclear factors from rabbit liver. Gene Exp. 3:151-162.
33. Ray A, Ray BK. 1996. A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells. Mol Cell Biol. 16:1584-1594.
34. Ray A, Schatten H, Ray BK. 1999. Activation of Sp1 and its functional cooperation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J Biol Chem. 274:4300-4308.
35. Ray BK, Ray A. 1993. Functional NF-kappa B element in rabbit serum amyloid A gene and its role in acute phase induction. Biochem Biophys Res Commun. 193:1159-1167.
36. Rienhoff HY Jr, Huang JH, Li X, Liao WSL. 1990. Molecular and cellular biology of serum amyloid A. Mol Biol Med. 7:287-298.
37. Sellar GC, Jordan SA, Bickmore WA, Fantes JA, Van Heyningen V, Ehitehead AS. 1994. The human serum amyloid A protein (SAA) superfamily gene cluster: mapping to chromosome 11p15.1 by physical and genetic linkage analysis. Genomics. 19:221-227.
38. Van Lenten BJ, Hama SY, deBeer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M. 1995. Anti-inflammatory HDL becomes proinflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 96:2758-2767.
39. Woo P, Sipe J, Dinarello CA, Colten HR. 1987. Structure of a human serum amyloid A gene and modulation of its expression in transfected L cells. J Biol Chem. 262:15790-15795.
40. Yamada T, Kluve-Beckerman B, Liepnieks JJ, Benson MD. 1994. Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta. 1226:323-329.